Stevanato Group S.p.A (STVN) Shares Outstanding (Diluted Average) (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Shares Outstanding (Diluted Average) of $319.6 million for Q1 2026, up 11.34% year-over-year from $287.1 million in Q1 2025, and up 0.58% on a QoQ basis from $317.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $319.6 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 11.34% year-over-year to $319.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $319.6 million (up 11.34% YoY) and the FY2025 annual result came in at $317.8 million, up 8.97% from the prior year.
- Shares Outstanding (Diluted Average) rose to $319.6 million in Q1 2026 per STVN's latest filing, from $317.8 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $319.6 million in Q1 2026 and bottomed at $362.98 in Q3 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $289.0 million (2023), against an average of $277.9 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) plunged 100.0%; it then jumped 79474654.22% in 2023.
- Tracing STVN's Shares Outstanding (Diluted Average) over 5 years: stood at $270.1 million in 2022, then gained by 5.78% to $285.7 million in 2023, then rose by 2.09% to $291.6 million in 2024, then advanced by 8.97% to $317.8 million in 2025, then climbed by 0.58% to $319.6 million in 2026.
- Per Business Quant, the three latest STVN Shares Outstanding (Diluted Average) figures stand at $319.6 million (Q1 2026), $317.8 million (Q4 2025), and $319.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.72 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 175.50 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 196.70 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.61 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.83 Mn |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | 319.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 319.61 Mn |
| Dec 31, 2025 | 317.78 Mn |
| Sep 30, 2025 | 319.15 Mn |
| Jun 30, 2025 | 308.91 Mn |
| Mar 31, 2025 | 287.06 Mn |
| Dec 31, 2024 | 291.62 Mn |
| Sep 30, 2024 | 299.70 Mn |
| Jun 30, 2024 | 293.77 Mn |
| Mar 31, 2024 | 288.97 Mn |
| Dec 31, 2023 | 285.66 Mn |
| Sep 30, 2023 | 288.48 Mn |
| Jun 30, 2023 | 289.00 Mn |
| Mar 31, 2023 | 284.86 Mn |
| Dec 31, 2022 | 270.06 Mn |
| Sep 30, 2022 | 362.98 |
| Jun 30, 2022 | 282.45 Mn |
| Mar 31, 2022 | 297.08 Mn |
| Dec 31, 2021 | 302.81 Mn |
| Sep 30, 2021 | 311.92 Mn |
| Jun 30, 2021 | 290.23 Mn |
| Mar 31, 2021 | 290.22 Mn |
| Dec 31, 2020 | 286.75 Mn |
| Sep 30, 2020 | 280.92 Mn |
| Jun 30, 2020 | 264.90 Mn |